UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving ...

Scientists have uncovered new genetic rules that determine whether the immune system’s “killer” T cells remain powerful long-term defenders or become worn out and ineffective. By building a detailed ...

Scientists at Texas A&M are turning an everyday pick-me-up into a high-tech medical switch. By combining caffeine with CRISPR ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers at MIT and Harvard have engineered stealth CAR-NK cells that avoid immune rejection and attack tumors more effectively ...

A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.

Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.

Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't respond to this immunotherapy for reasons not yet fully understood.

Illustration of a T lymphocyte white blood cell, depicted in blue, attacking a cancer cell, shown in red Nemes Laszlo / Science Photo Library via Getty Images CAR T-cell therapy can be a lifesaving ...